Beschreibung

Accomplished biotech leader and consultant with proven track record from global strategy through development/operations to partnering and commercialisation and company financing. Hands-on experience in all stages of the pharmaceutical and biotech industry value chain including registrations in EU, US, CA, JP for antibodies and microbial peptides/proteins especially with biosimilars. First-hand experience with nanotechnology, innovative antibodies, complex generics, diagnostics and delivery devices. Experience with CDMO business as provider and customer. Broad therapeutic area expertise from immunology to oncology, including hematological malignancies, solid tumors, dermatology, MS, RA, T1D, asthma, opththalmology, nephrology, orphan diseases.

Sprachen

Deutsch
Muttersprachlich oder zweisprachig
Englisch
Verhandlungssicher
Französisch
Konversationssicher
Italienisch
Grundkenntnisse

Arbeitsortpräferenzen

Vor Ort möglich

Munich (bis zu 50 km)

Martin Biotech Consulting
Independent Consultant
BIOTECHNOLOGIE
Januar 2023 - Heute (3 Jahre und 5 Monate)
Munich, BY, Germany
Supporting investors and clients in the global pharmaceutical and biotech industries with interim management, valuations, due diligence, business strategy, operations management, start-up activities, drug development, BD&L, partnering, alliance management and financing in the areas of innovative biotechnology, biosimilars and generics.
Topas Therapeutics GmbH
Chief Executive Officer
August 2020 - Dezember 2022 (2 Jahre und 4 Monate)
Hamburg, Germany
Growing a leading player in antigen-specific immune tolerance to treat autoimmune diseases, allergies and anti-drug immune responses. Build a leading team. Fundraising with VCs. Build a platform technology and progress clinical-stage pipeline.
Apotex Inc.
President, Apobiologix
Januar 2018 - Mai 2020 (2 Jahre und 4 Monate)
Toronto, ON, Canada
Leading Apotex biologics division, focusing on the development and commercialisation of oncology biosimilars and complex generics in North America and other global markets. Member of Apotex Global Executive Committee.